Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Lung transplantation for lymphangioleiomyomatosis

Article Abstract:

Lung transplantation appears to be an effective treatment for lymphangioleiomyomatosis. Lymphangioleiomyomatosis is a disease that affects the lungs and can lead to death from respiratory failure. Researchers reviewed the cases of 34 patients who received a lung transplant for this condition. Sixty-nine percent survived one year after transplant and 58% survived two years. Lung function improved significantly 6 months after transplantation. They also experienced many complications including hemorrhage, infection and recurring disease in the transplanted lung.

Author: Weder, Walter, Boehler, Annette, Speich, Rudolf, Russi, Erich W.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
Care and treatment, Lungs, Lung diseases, Lung transplantation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

Article Abstract:

A scanner that combines CT scanning and PET scanning may be more effective in detecting non-small-cell lung cancer than either scan alone, according to a study of 50 patients. CT scans can locate a tumor, but cannot tell whether it is benign or malignant. PET scans can distinguish between benign and malignant tumors, but it also highlights inflammation not caused by cancer. The integrated CT-PET scanner combines the best features of both techniques and eliminates the drawbacks.

Author: Lardinois, Didier, Weder, Walter, Hany, Thomas F., Kamel, Ehab M., Korom, Stephan, Seifert, Burkhardt, Schulthess, Gustav K. von, Steinert, Hans C.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Innovations, Diagnosis, CT imaging, CAT scans, PET imaging, Positron emission tomography, Lung cancer, Non-small cell, Non-small cell lung cancer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Article Abstract:

Study reveals that type 2 diabetic patients receiving recombinant human interleukin-1-receptor antagonist had improved glycemic control due to enhanced beta-cell secretory function.

Author: Seifert, Burkhardt, Larsen, Claus M, Faulenbach, Mirjam, Vaag, Alla, Volund, Aage, Ehses, Jan A, Mandrup-Poulsen, Thomas, Donath, Marc Y.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Science & research, Research, Drug therapy, Type 2 diabetes, Dosage and administration, Interleukin-1, Clinical report, Anakinra

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: Histamine-2-receptor antagonists: standard therapy for acid-peptic diseases. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration
  • Abstracts: The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Effects of blood pressure drugs in patients with diabetes and kidney disease
  • Abstracts: Brief interventions for alcohol problems in hospital settings. Alcohol-related health problems in general hospitals
  • Abstracts: Inflammation and cancer. Mast cells in autoimmune disease. eLixiRs for restraining inflammation
  • Abstracts: Withdrawal syndrome. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.